대한방사성의약품학회지 (Journal of Radiopharmaceuticals and Molecular Probes)

  • 제9권1호
  • /
  • Pages.43-48
  • /
  • 2023
  • /
  • 2384-1583(pISSN)
  • /
  • 2508-3848(eISSN)
대한방사성의약품학회 (Korean Society of Radiopharmaceuticals and Molecular Probes)
권호 표지
DOI QR코드

DOI QR Code

In vivo Trafficking of Liposomes Containing Boron Compounds for Boron Neutron Capture Therapy (BNCT)

  • Huu Bao Nguyen (Department of Molecular Medicine, Brain Korea 21 four KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, School of Medicine, Kyungpook National University) ;
  • Jeongsoo Yoo (Department of Molecular Medicine, Brain Korea 21 four KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, School of Medicine, Kyungpook National University)
  • 투고 : 2023.06.07
  • 심사 : 2023.06.13
  • 발행 : 2023.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

For over 50 years, boron neutron capture therapy (BNCT) has been steadily developed for treating various cancers. This is a non-invasive, selective, and targeted radiotherapy wherein boron-rich molecules accumulate at the tumor site. Liposomal vesicles have become a popular and effective drug delivery system for BNCT, with strategies including surface decoration, bilayer integration, and hydrophilic core encapsulation. This review highlights the state-of-the-art uses of liposomes in BNCT and elucidates a new perspective where BNCT can be used with radiotracer guidance in all-in-one delivery systems.

키워드

과제정보

This work was supported by the R&D program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (No.2022M2E7A2019023, 2019M2D3A2060217, and RS-2022-00197770).

참고문헌

  1. Locher GL. Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol Radium Ther Nucl Med 1936;36:1-13.
  2. William HS. The uses of nuclear disintegration in the diagnosis and treatment of brain cancer. N Engl J Med 1951;245(23):875-8. https://doi.org/10.1056/NEJM195112062452301
  3. Dymova MA, Taskaev SY, Richter VA, Kuligina EV. Boron neutron capture therapy: Current status and future perspectives. Cancer Commun 2020;40:406-21. https://doi.org/10.1002/cac2.12089
  4. Soloway AH, Hatanaka H, Davis MA. Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron Compounds. J Med Chem 1967;10:714-7. https://doi.org/10.1021/jm00316a042
  5. Abolfazl A, Rogaie R, Soodabeh D, Sang WJ, Nosratollah Z, Younes H, Mohammad S, Mohammad K, Kazem N. Liposome: classification, preparation, and applications. Nanoscale Res Lett 2013;8:102.
  6. Mingyuan L, Chunyang D, Na G, Yuou T, Xin M, Hua S, Shuangshuang L, Peng Y, Herve G. Composition design and medical application of liposomes. Eur J Med Chem 2019;164:640-53. https://doi.org/10.1016/j.ejmech.2019.01.007
  7. Yechezkel CB. Doxil® - The first FDA-approved nano-drug: Lessons learned. J Control Release 2012;160(2):117-34. https://doi.org/10.1016/j.jconrel.2012.03.020
  8. Farr LE, Sweet WH, Locksley HB, Robertson JS. Neutron Capture Therapy of Gliomas Using Boron. Trans Am Neurol Assoc 1954;13:110-3.
  9. Hatanaka H. Boron neutron capture therapy for tumors. In: Karim ABMF, Laws ER, editors. Glioma. Berlin Heidelberg: Springer-Verlag; 1991.p.233-49
  10. Burian J, Jansky B, Marek M, Novak E, Viererbl L, Fernandes AC, Kaschuck YA, Trykov LA, Volkov VS. Development of Equipments for Determination of BNCT Source Spectral, Parameters. Appl Radiat Isotopes 2004;61:849-52. https://doi.org/10.1016/j.apradiso.2004.05.064
  11. Burian J, Marek M, Rataj J, Flibor S, Rejchrt J, Vicrerbl L, Sus F, Honova H, Petruzelka L, Prokes K, Tovarys F, Dbaly V, Benes V, Kozler P, Honzatko J, Tomandl I, Mares V. Report on the First Patient Group of the Phase I BNCT Trial at the LVR-15 Reactor. Int Congr Ser 2004;1259:27-32. https://doi.org/10.1016/S0531-5131(03)01515-2
  12. Miyatake S, Kajimoto Y, Kawabata S, Yokoyama K, Kuroiwa K, Ono O. Modified Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using Epithermal Neutron and Two Boron Compounds With Different Accumulation Mechanisms: Effectiveness of BNCT on Radiographic Images. Neuro-Oncology 2005;7:349-50.
  13. Miyatake S, Kawabata S, Kajimoto Y, Aoki AH, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, Sakurai Y, Masugana S, Nagata K, Maruhashi A, Ono K. Modified Boron Neutron Capture Therapy for Malignant Gliomas Performed Using Epithermal Neutron and Two Boron Compounds With Different Accumulation Mechanisms: An Efficacy Study Based on Findings on Neuroimages. J Neurosurg 2005; 103:1000-9. https://doi.org/10.3171/jns.2005.103.6.1000
  14. Yamamoto T, Matsumura A, Nakai K, Shibata Y, Endo K, Sakurai F, Kishi T, Kumada H, Yamamoto K, Torii Y. Current Clinical Results of the Tsukuba BNCT Trial. Appl Radiat Isot 2004;61:1089-93. https://doi.org/10.1016/j.apradiso.2004.05.010
  15. Yanagie H, Higashi S, Seguchi K, Ikushima I, Fujihara M, Nonaka Y, Oyama K, Maruyama S, Hatae R, Suzuki M, Masunaga S, Kinashi T, Sakurai Y, Tanaka H, Kondo N, Narabayashi M, Kajiyama T, Maruhashi A, Ono K, Nakajima J, Ono M, Takahashi H, Eriguchi M. Pilot Clinical Study of Boron Neutron Capture Therapy for Recurrent Hepatic Cancer Involving the Intra-Arterial Injection of a (BSH)-B-10-Containing WOW Emulsion. Appl Radiat Isotopes 2014;88:32-7. https://doi.org/10.1016/j.apradiso.2014.01.014
  16. Wittig A, Malago M, Collette L, Huiskamp R, Buhrmann S, Nievaart V, Kaiser GM, Jockel K, Schmid KW, Ortmann U, Sauerwein WA. Uptake of Two 10B-Compounds in Liver Metastases of Colorectal Adenocarcinoma for Extracorporeal Irradiation With Boron Neutron Capture Therapy (EORTC Trial 11001). Int J Cancer 2008;122:1164-71. https://doi.org/10.1002/ijc.23224
  17. Wang S, Zhang Z, Miao L, Li Y. Boron Neutron Capture Therapy: Current Status and Challenges. Front Oncol 2022;12.
  18. Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H, Karashima H, Kobayashi T, Kanda K, Yoshino K. Treament of Malignant Melanoma by Single Thermal Neutron Capture Therapy With Melanoma-Seeking 10B-Compound. Lancet 1989;2:388-9. https://doi.org/10.1016/S0140-6736(89)90567-9
  19. Fukuda H, Hiratsuka J, Kobayashi T, Sakurai Y, Yoshino K, Karashima H, Turu K, Araki K, Mishima Y, Ichihashi M. Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma With Special Reference to Absorbed Doses to the Normal Skin and Tumor. Australias Phys Eng Sci Med 2003;26(3):97-103. https://doi.org/10.1007/BF03178777
  20. Diaz AZ. Assessment of the Results From the Phase FII Boron Neutron Capture Therapy Trials at the Brookhaven National Laboratory From a Clinician's Point of View. J Neuro-Oncol 2003;62:101-9. https://doi.org/10.1007/BF02699937
  21. Mingyuan L, Chunyang D, Na G, Yuou T, Xin M, Hua S, Shuangshuang L, Peng Y, Herve G, Composition design and medical application of liposomes, Eur J Med Chem 2019;164:640-53. https://doi.org/10.1016/j.ejmech.2019.01.007
  22. Zavjalov E, Zaboronok A, Kanygin V, Kasatova A, Kichigin A, Mukhamadiyarov R, Razumov I, Sycheva T, Mathis BJ, Maezono SEB, Matsumura A, Taskaev S. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice. Int J Radiat Biol 2020;96(7);868-78. https://doi.org/10.1080/09553002.2020.1761039
  23. Lee W, Sarkar S, Ahn H, Kim JY, Lee YJ, Chang Y, Yoo J. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT). Biochem Biophys Res Commun 2020;522(3):669-75. https://doi.org/10.1016/j.bbrc.2019.11.144
  24. Lee W, Kim KW, Lim JE, Sarkar S, Kim JY, Chang Y, Yoo J. In vivo evaluation of the effects of combined boron and gadolinium neutron capture therapy in mouse models. Sci Rep 2022;12:13360.
  25. Matsumura A, Zhang T, Nakai K, Endo K, Kumada H, Yamamoto T, Yoshida F, Sakurai Y, Yamamoto K, Nose T. Combination of boron and gadolinium compounds for neutron capture therapy: An in vitro study. J Exp Clin Cancer Res 2005;24:93-8.
  26. Nel AE, Mei K, Liao Y, Liu S. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogenous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs. ACS Nano. 2022;16(4):5184-232. https://doi.org/10.1021/acsnano.2c01252
  27. Li J, Sun Q, Lu C, Xiao H, Guo Z, Duan D, Zhang Z, Liu T, Liu Z. Boron encapsulated in a liposome can be used for combinational neutron capture therapy. Nat Commun 2022;13:2143.
  28. Bregadze VI, Sivaev IB, Dubey RD, Semioshkin A, Shmal'ko AV, Kosenko ID, Lebedeva KV, Mandal S, Sreejyothi P, Sarkar A, Shen Z, Wu A, Hosmane NS. Boron-Containing Lipids and Liposomes: New Conjugates of Cholesterol with Polyhedral Boron Hydrides. Chem Eur J 2020;26:13832.
  29. Shirakawa M, Zaboronok A, Nakai K, Sato Y, Kayaki S, Sakai T, Tsurubuchi T, Yoshida F, Nishiyama T, Suzuki M, Tomida H, Matsumura A. A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy. Cells 2021;10(12):3421.
  30. Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y. Synthesis and Radiation Dosimetry of 4-Borono-2-[18F]fluoro-D,L-phenylalanine: a Target Compound for PET and Boron Neutron Capture Therapy. Int J Radiat Appl Instrum Part A 1991;42(4):325-8. https://doi.org/10.1016/0883-2889(91)90133-L
  31. Sauerwein WAG, Sancey L, Hey-Hawkins E, Kellert M, Panza L, Imperio D, Balcerzyk M, Rizzo G, Scalco E, Herrmann K, Mauri PL, Palma AD, Wittig A. Theranostics in Boron Neutron Capture Therapy. Life 2021;11(4):330.
  32. Feiner IVJ, Pulagam KR, Gomez-Vallejo V, Zamacola K, Baz Z, Caffarel MM, Lawrie CH, Ruiz-de-Angulo A, Carril M, Llop J. Therapeutic Pretargeting with Gold Nanoparticles as Drug Candidates for Boron Neutron Capture Therapy. Part Part Syst Charact 2020;37:2000200.
  33. Pulagam KR, Gona KB, Gomez-Vallejo V, Meijer J, Zillberfain C, Estrela-Lopis I, Baz Z, Cossio U, Llop J. Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation. Molecules 2019;24:3609.
  34. Shi Y, Li J, Zhang Z, Duan D, Zhang Z, Liu H, Liu T, Liu Z. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy. ACS Appl Mater Interface 2018;10:43387-95. https://doi.org/10.1021/acsami.8b14682